11:39 AM EST - Lorus Therapeutics Inc. : reported financial results for the 12 months ended May 31, 2011. Loss from operations for the fiscal year decreased to $5.0 million ($0.38 per share) compared to $5.7 million ($0.61 per share) for the year ended May 31, 2010. For the year ended May 31, 2011 net loss and other comprehensive loss was $5.0 million ($0.38 per share) compared with net earnings and other comprehensive earnings of $5.3 million (earnings of $0.57 per share) for the year ended May 31, 2010 as a result of a $11.0 million gain on sale recognized on the extinguishment of the convertible debentures in June 2009. Lorus Therapeutics Inc.
shares T.LOR are trading even at $0.34.
